DNV, the independent global assurance and risk management provider, is partnering with Korean AI-driven blood and cancer ...

Alamar Biosciences Announces Launch of NULISAqpcr™ AD 5-plex Assay, Advancing Blood Based Biomarker Detection in Alzheimer's ...

Manifold Health AI was created after identifying a fundamental limitation in the at-home diagnostics market: while self-administered blood collection technology is now exceptional, devices alone do ...

The Global Alzheimer's Platform Foundation(R) (GAP) is pleased to welcome Spear Bio, a biotechnology company pioneering wash-free ultrasensitive immunoassay technology, to the Bio-Hermes-002 study.

Alamar Biosciences, Inc. ("Alamar"), a leader in precision proteomics dedicated to advancing the early detection of disease, is proud to announce the launch of its Research Use Only (RUO) ...

The biotechnology company introduces its blood-based testing solution for Alzheimer's disease research, offering researchers an advanced tool to detect multiple biomarkers simultaneously through the ...

Tal Parnes, Chairman of the Board of Inspira Technologies, stated: “The contemplated acquisition of this liquid biopsy platform represents a significant value inflection point for Inspira, adding a ...

A nasal spray vaccine protected ferrets from lethal H5N1 and cleared nasal virus fast. Here’s what the animal data shows and ...

Guardant co-CEO Helmy Eltoukhy says the shift to personalized treatment and earlier diagnosis is here at the WIRED Health ...

Alamar Biosciences, Inc. ("Alamar"), a leader in precision proteomics dedicated to advancing the early detection of disease, is proud to announce ...

Quince Therapeutics (QNCX) rated Buy ahead of Phase 3 NEAT readout in A-T; eDSP targets $1B+ orphan market with strong cash ...

India’s IT services industry has long prioritised data security due to global client requirements. DPDP changes the nature of ...